Overview
The Translational Core provides investigators with the expertise and technologies needed to advance laboratory discoveries toward clinically meaningful applications. It bridges mechanistic research with drug-focused and biomarker-driven strategies to accelerate therapeutic development.
The Core maintains advanced imaging and analytical resources, including wide-field and confocal fluorescence microscopy, quantitative image analysis, and customized analysis solutions. It also supports the development of 3D culture systems such as patient-derived organoids and spheroid models, along with specialized functional and drug-response assays.
In addition, the Core offers study design consultation, target validation strategies, assay development, integrated molecular and cellular analyses, bioinformatics support, and assistance with grant and collaborative program development.
Equipment/Services
Contacts
John Maringa Girthanka, PhD Director john.githaka@hsc.wvu.edu 304-293-0723
Acknowledgements
Please remember to acknowledge support for the Translational Core in all your publications:
Assay [insert service name] were performed in the West Virginia University Translational Core which has been supported by the WVU Cancer Institute and the Department of Medical Oncology.
